This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit

Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Hybrid Event, 20 - 24 June 2022
In-Person: Clayton Hotel Burlington Road, Dublin, IrelandDigital Experience: One track will be live-streamed each day in BST time zone, with on-demand recording access for all other tracks made available from the afternoon of the following day. Learn more on the Digital Experience page.

Alex Denoon
Partner at Bristows LLP


Alex is passionate about the Life Sciences sector and advises about regulatory issues all day every day. Alex’s advice is informed by a BSc in Human Genetics and in-house experience, including as GC of a biopharmaceutical company, and brings 25 years’ experience advising clients in the sector.

In addition to a wide array of contentious (judicial review) matters, he enjoys working with clients to devise and implement regulatory strategies throughout the product life cycle of pharmaceuticals and medical devices (including in vitro diagnostics).

Alex advises clients in relation to challenging issues including genomics, cell and gene therapies, 3D printing, healthcare Apps, companion diagnostics, borderline products and combination products.

The Life Sciences sector sees some of the most exciting and influential deployments of Artificial Intelligence and machine learning. The increasing use of AI in the sector poses a number of regulatory challenges (including entirely new regulations) and he specialises in helping clients navigate these.

Alex has been involved in the development of a number of regulatory frameworks and guidelines.

Legal 500 describes Alex as “a straight-talking, commercially astute technology specialist who is always willing to take a view” and who delivers “out-of-the-box solutions”.

Agenda Sessions

  • Transitioning from MDD to MDR and IVDD to IVDR: What Are the Critical Changes?